Bio-Rad Laboratories
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BIO and other ETFs, options, and stocks.About BIO
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Science and Clinical Diagnostics segments.
CEONorman D. Schwartz
CEONorman D. Schwartz
Employees7,700
Employees7,700
HeadquartersHercules, California
HeadquartersHercules, California
Founded1952
Founded1952
Employees7,700
Employees7,700
BIO Key Statistics
Market cap9.33B
Market cap9.33B
Price-Earnings ratio28.95
Price-Earnings ratio28.95
Dividend yield—
Dividend yield—
Average volume249.50K
Average volume249.50K
High today$342.11
High today$342.11
Low today$337.22
Low today$337.22
Open price$337.65
Open price$337.65
Volume129.95K
Volume129.95K
52 Week high$387.99
52 Week high$387.99
52 Week low$211.43
52 Week low$211.43
BIO News
Simply Wall St 1d
Bio-Rad Laboratories: Evaluating Valuation After Major Oncology Diagnostics Partnership Expansion with BiodesixBio-Rad Laboratories and Biodesix are expanding their partnership to develop and clinically validate new in vitro diagnostic assays targeting oncology applicati...
Nasdaq 3d
BIO Crosses Above Average Analyst TargetIn recent trading, shares of Bio-Rad Laboratories Inc (Symbol: BIO) have crossed above the average analyst 12-month target price of $331.40, changing hands for...
Simply Wall St 4d
Is Bio-Rad Using Biodesix Collaboration to Deepen Its Precision Oncology Ambitions?Biodesix, Inc. recently announced an expanded partnership with Bio-Rad Laboratories to develop and seek regulatory approval for new in vitro diagnostic assays b...
Analyst ratings
63%
of 8 ratingsBuy
62.5%
Hold
37.5%
Sell
0%
People also own
Based on the portfolios of people who own BIO. This list is generated using Robinhood data, and it’s not a recommendation.